DE69330601T2 - Serotoninergische ergolin derivate - Google Patents
Serotoninergische ergolin derivateInfo
- Publication number
- DE69330601T2 DE69330601T2 DE69330601T DE69330601T DE69330601T2 DE 69330601 T2 DE69330601 T2 DE 69330601T2 DE 69330601 T DE69330601 T DE 69330601T DE 69330601 T DE69330601 T DE 69330601T DE 69330601 T2 DE69330601 T2 DE 69330601T2
- Authority
- DE
- Germany
- Prior art keywords
- inergic
- seroton
- ergolin
- derivatives
- ergolin derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
- C07D457/08—Lysergic acid amides in which the amide nitrogen is a member of a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
- C07D457/12—Nitrogen atoms
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929226967A GB9226967D0 (en) | 1992-12-24 | 1992-12-24 | Serotoninergic ergoline derivatives |
GB939305696A GB9305696D0 (en) | 1993-03-19 | 1993-03-19 | Scrotoninergic ergoline derivatives |
PCT/EP1993/003337 WO1994014806A1 (en) | 1992-12-24 | 1993-11-26 | Serotoninergic ergoline derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69330601D1 DE69330601D1 (de) | 2001-09-20 |
DE69330601T2 true DE69330601T2 (de) | 2002-07-04 |
Family
ID=26302231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69330601T Expired - Fee Related DE69330601T2 (de) | 1992-12-24 | 1993-11-26 | Serotoninergische ergolin derivate |
Country Status (22)
Country | Link |
---|---|
US (1) | US5430031A (de) |
EP (1) | EP0628042B1 (de) |
JP (1) | JP3337688B2 (de) |
KR (1) | KR100325274B1 (de) |
CN (1) | CN1043230C (de) |
AT (1) | ATE204278T1 (de) |
AU (1) | AU669597B2 (de) |
CA (1) | CA2125288C (de) |
DE (1) | DE69330601T2 (de) |
DK (1) | DK0628042T3 (de) |
ES (1) | ES2162856T3 (de) |
FI (1) | FI943839A (de) |
HU (1) | HU220391B (de) |
IL (1) | IL108085A (de) |
MX (1) | MX9400165A (de) |
NZ (1) | NZ258559A (de) |
PL (1) | PL304893A1 (de) |
PT (1) | PT628042E (de) |
RU (1) | RU2131427C1 (de) |
TW (1) | TW252979B (de) |
UA (1) | UA41880C2 (de) |
WO (1) | WO1994014806A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9407637D0 (en) | 1994-04-18 | 1994-06-08 | Erba Carlo Spa | Serotoninergic abeo-ergoline derivatives |
EP1685838A1 (de) * | 2000-08-16 | 2006-08-02 | Pharmacia & Upjohn Company LLC | Verbindungen zur Behandlung von Suchterkrankungen |
CA2413762A1 (en) * | 2000-08-16 | 2002-02-21 | Pharmacia & Upjohn Company | Compounds for the treatment of addictive disorders |
RU2277539C2 (ru) * | 2001-06-08 | 2006-06-10 | Сосьете Де Консей Де Решерш Э Д`Аппликасьон Сьентифик С.А.С. | Химерные аналоги соматостатина-дофамина |
SI21351A (sl) * | 2002-12-17 | 2004-06-30 | LEK farmacevtska dru�ba d.d. | Zdravljenje odvisnosti od psihostimulansov |
TWI523863B (zh) | 2012-11-01 | 2016-03-01 | 艾普森藥品公司 | 體抑素-多巴胺嵌合體類似物 |
US9777039B2 (en) | 2012-11-01 | 2017-10-03 | Ipsen Pharma S.A.S. | Somatostatin analogs and dimers thereof |
CN106866656A (zh) * | 2017-02-28 | 2017-06-20 | 西南交通大学 | 一类麦角碱衍生物及其在预防和治疗精神疾病的用途 |
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
KR20220008824A (ko) | 2019-04-17 | 2022-01-21 | 컴퍼스 패쓰파인더 리미티드 | 실로시빈으로 불안 장애, 두통 장애 및 섭식 장애를 치료하는 방법 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2802023A1 (de) * | 1977-01-28 | 1978-08-03 | Sandoz Ag | Neue ergotderivate, ihre herstellung und verwendung |
US4382940A (en) * | 1979-12-06 | 1983-05-10 | Farmitalia Carlo Erba S.P.A. | Ercoline derivatives and therapeutic compositions having CNS affecting activity |
GB8714767D0 (en) * | 1987-06-24 | 1987-07-29 | Erba Farmitalia | Egoline derivatives |
FI76085C (fi) * | 1981-07-21 | 1988-09-09 | Erba Farmitalia | Foerfarande foer framstaellning av ergolinderivat. |
CH649300A5 (de) * | 1981-08-07 | 1985-05-15 | Sandoz Ag | Ergopeptinderivate, ihre herstellung und verwendung. |
YU254782A (en) | 1981-12-18 | 1986-10-31 | Schering Ag | Process for making new ergot anilides |
DE3309493A1 (de) * | 1983-03-14 | 1984-09-20 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue ergolin-derivate, verfahren zu ihrer herstellung sowie verwendung als arzneimittel |
PH21123A (en) * | 1983-04-28 | 1987-07-27 | Erba Farmitalia | Ergoline derivatives |
DE3445784A1 (de) * | 1984-12-13 | 1986-06-26 | Schering AG, Berlin und Bergkamen, 1000 Berlin | Verfahren zur herstellung von ergolin-derivaten |
GB8501078D0 (en) * | 1985-01-16 | 1985-02-20 | Erba Farmitalia | Piperazin-1-yl-ergo-line derivatives |
GB8515528D0 (en) * | 1985-06-19 | 1985-07-24 | Erba Farmitalia | Ergoline derivatives |
DE3533672A1 (de) * | 1985-09-19 | 1987-03-26 | Schering Ag | Neue 12- und 13-substituierte ergolinderivate |
US4939258A (en) * | 1985-10-01 | 1990-07-03 | Eli Lilly And Company | Cycloalkanol esters of dihydrolysergic acid |
US4968802A (en) * | 1985-10-01 | 1990-11-06 | Eli Lilly And Company | Process of making alkoxy cycloalkanol esters of dihydrolysergic acid |
DE3535929A1 (de) * | 1985-10-04 | 1987-04-09 | Schering Ag | 1,2-disubstituierte ergolinderivate |
GB8612366D0 (en) * | 1986-05-21 | 1986-06-25 | Erba Farmitalia | Ergoline esters |
DE3620293A1 (de) * | 1986-06-16 | 1987-12-17 | Schering Ag | 1-und/oder 2-substituierte ergolinderivate |
DE3623438C2 (de) * | 1986-07-10 | 1998-04-09 | Schering Ag | In 2-Stellung mit radioaktivem Iod markierte Ergolinylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Diagnostika |
GB8702364D0 (en) * | 1987-02-03 | 1987-03-11 | Erba Farmitalia | Ergolinyl heterocycles |
US4931447A (en) * | 1987-06-15 | 1990-06-05 | Eli Lilly And Company | Cycloalkylamides of (8β)-1-alkyl-6-(substituted) ergolines |
US4843703A (en) * | 1987-07-07 | 1989-07-04 | Truth Incorporated | Method of assembling a window operator |
ES2032570T3 (es) * | 1987-11-20 | 1993-02-16 | Farmitalia Carlo Erba S.R.L. | Derivados antiparkinson de ergolina. (reserva del art. 167.2 cpe). |
DE3824659A1 (de) * | 1988-07-15 | 1990-02-08 | Schering Ag | 2-, 12- oder 13-substituierte 3-(8'(alpha)-ergolinyl)-1,1-diethylharnstoffe, ihre herstellung und verwendung in arzneimitteln |
GB8824744D0 (en) * | 1988-10-21 | 1988-11-30 | Erba Carlo Spa | Antiemesis ergoline derivatives |
US4902691A (en) * | 1988-12-19 | 1990-02-20 | Eli Lilly And Company | Heteroalkylamides of (8-β)-1-alkyl-6-(substituted)ergolines useful for blocking 5HT2 receptors |
DE3913756A1 (de) * | 1989-04-21 | 1990-10-25 | Schering Ag | 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung |
WO1991011447A1 (en) * | 1990-01-25 | 1991-08-08 | Farmitalia Carlo Erba S.R.L. | Process for preparing ergoline derivatives |
-
1993
- 1993-11-26 WO PCT/EP1993/003337 patent/WO1994014806A1/en active IP Right Grant
- 1993-11-26 AU AU56286/94A patent/AU669597B2/en not_active Ceased
- 1993-11-26 DK DK94901903T patent/DK0628042T3/da active
- 1993-11-26 PT PT94901903T patent/PT628042E/pt unknown
- 1993-11-26 DE DE69330601T patent/DE69330601T2/de not_active Expired - Fee Related
- 1993-11-26 AT AT94901903T patent/ATE204278T1/de not_active IP Right Cessation
- 1993-11-26 RU RU94040382A patent/RU2131427C1/ru not_active IP Right Cessation
- 1993-11-26 EP EP94901903A patent/EP0628042B1/de not_active Expired - Lifetime
- 1993-11-26 ES ES94901903T patent/ES2162856T3/es not_active Expired - Lifetime
- 1993-11-26 PL PL93304893A patent/PL304893A1/xx unknown
- 1993-11-26 KR KR1019940702946A patent/KR100325274B1/ko not_active IP Right Cessation
- 1993-11-26 UA UA94085718A patent/UA41880C2/uk unknown
- 1993-11-26 NZ NZ258559A patent/NZ258559A/en unknown
- 1993-11-26 JP JP51472394A patent/JP3337688B2/ja not_active Expired - Fee Related
- 1993-11-26 CA CA002125288A patent/CA2125288C/en not_active Expired - Fee Related
- 1993-11-26 TW TW082109975A patent/TW252979B/zh active
- 1993-11-26 HU HU9401951A patent/HU220391B/hu not_active IP Right Cessation
- 1993-12-20 US US08/169,177 patent/US5430031A/en not_active Expired - Fee Related
- 1993-12-20 IL IL10808593A patent/IL108085A/en not_active IP Right Cessation
- 1993-12-23 CN CN93112788A patent/CN1043230C/zh not_active Expired - Fee Related
-
1994
- 1994-01-03 MX MX9400165A patent/MX9400165A/es unknown
- 1994-08-19 FI FI943839A patent/FI943839A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1093087A (zh) | 1994-10-05 |
RU2131427C1 (ru) | 1999-06-10 |
CA2125288C (en) | 2004-11-23 |
US5430031A (en) | 1995-07-04 |
FI943839A0 (fi) | 1994-08-19 |
JP3337688B2 (ja) | 2002-10-21 |
EP0628042A1 (de) | 1994-12-14 |
HUT68190A (en) | 1995-05-29 |
RU94040382A (ru) | 1996-07-10 |
CN1043230C (zh) | 1999-05-05 |
PL304893A1 (en) | 1995-01-09 |
IL108085A (en) | 1996-10-16 |
HU9401951D0 (en) | 1994-09-28 |
EP0628042B1 (de) | 2001-08-16 |
KR100325274B1 (ko) | 2002-08-14 |
TW252979B (de) | 1995-08-01 |
IL108085A0 (en) | 1994-04-12 |
DE69330601D1 (de) | 2001-09-20 |
HU220391B (hu) | 2002-01-28 |
WO1994014806A1 (en) | 1994-07-07 |
UA41880C2 (uk) | 2001-10-15 |
AU5628694A (en) | 1994-07-19 |
NZ258559A (en) | 1996-07-26 |
ES2162856T3 (es) | 2002-01-16 |
FI943839A (fi) | 1994-08-19 |
ATE204278T1 (de) | 2001-09-15 |
CA2125288A1 (en) | 1994-07-07 |
DK0628042T3 (da) | 2001-11-12 |
JPH07504207A (ja) | 1995-05-11 |
PT628042E (pt) | 2002-01-30 |
KR950700293A (ko) | 1995-01-16 |
MX9400165A (es) | 1994-07-29 |
AU669597B2 (en) | 1996-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL124537A0 (en) | Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same | |
ATE202337T1 (de) | Cyclopropylalkansäurederivate | |
EA200400432A1 (ru) | Производные мочевины | |
DE69325454D1 (de) | Taxol-derivate | |
RU2088589C1 (en) | Derivatives of 17 beta-substituted-4-aza-5-5 alpha-androstane-3-ones, methods of synthesis of compounds, pharmaceutical composition, compound 4 | |
ES2097174T3 (es) | Derivados de la 2-ciclohexan-1-il amina. | |
AP9801378A0 (en) | 9-amino-3- keto erythromycin derivatives. | |
EA200100983A1 (ru) | Производные 13-метилэритромицина | |
PT992509E (pt) | Novos derivados macrolidos | |
ES2160602T3 (es) | Derivados de quinolona y acridinona para el tratamiento de la incontinencia urinaria. | |
EA199801028A1 (ru) | Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний | |
KR960703863A (ko) | 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer) | |
DE69330601T2 (de) | Serotoninergische ergolin derivate | |
CA2219359A1 (en) | Hydantoin derivatives as intermediates for pharmaceutical active compounds | |
AU1998995A (en) | Substituted fused and bridged bicyclic compounds as therapeutic agents | |
AP9801235A0 (en) | Erythromycin derivatives. | |
ATE282608T1 (de) | Chinoxalindionen | |
EA199900688A1 (ru) | Хиноксалиндионы | |
AU567498B2 (en) | 5-phenyl-1h-2,3-dihydro-1,4-benzodiazepine derivatives. | |
FI911616A0 (fi) | Substituerade 3-tia- eller 3-oxa-alkyl -flavoner, foerfarande foer deras framstaellning, deras anvaendning, pao dessa foereningar baserade laekemedel samt mellanprodukter. | |
DK0952157T3 (da) | 9a, 11b-dehydroderivater af 9-oxim-3-keto-6-0-methylerythromycin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |